Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$126.43 - $145.6 $1.71 Million - $1.97 Million
-13,544 Reduced 24.77%
41,140 $5.99 Million
Q1 2023

May 09, 2023

SELL
$121.91 - $130.94 $2.96 Million - $3.18 Million
-24,267 Reduced 30.74%
54,684 $7.07 Million
Q4 2022

Feb 14, 2023

BUY
$104.7 - $128.4 $660,238 - $809,690
6,306 Added 8.68%
78,951 $10.1 Million
Q3 2022

Nov 08, 2022

SELL
$101.65 - $119.27 $27,038 - $31,725
-266 Reduced 0.36%
72,645 $7.6 Million
Q2 2022

Aug 11, 2022

SELL
$102.23 - $133.85 $89,451 - $117,118
-875 Reduced 1.19%
72,911 $7.66 Million
Q1 2022

May 12, 2022

SELL
$108.42 - $129.58 $800,031 - $956,170
-7,379 Reduced 9.09%
73,786 $9.44 Million
Q4 2021

Feb 11, 2022

BUY
$115.43 - $146.63 $1.81 Million - $2.3 Million
15,707 Added 24.0%
81,165 $10.3 Million
Q3 2021

Nov 12, 2021

BUY
$136.35 - $158.76 $8.93 Million - $10.4 Million
65,458 New
65,458 $9.58 Million
Q4 2018

Feb 12, 2019

SELL
$94.4 - $126.76 $5.77 Million - $7.74 Million
-61,081 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$108.41 - $127.64 $2.94 Million - $3.46 Million
-27,086 Reduced 30.72%
61,081 $8.03 Million
Q2 2018

Jul 20, 2018

SELL
$102.12 - $114.04 $2.8 Million - $3.13 Million
-27,447 Reduced 23.74%
88,167 $9.83 Million
Q1 2018

Apr 24, 2018

SELL
$104.31 - $124.46 $2.82 Million - $3.37 Million
-27,067 Reduced 18.97%
115,614 $12.6 Million
Q4 2017

Feb 13, 2018

BUY
$105.55 - $120.83 $6.39 Million - $7.31 Million
60,533 Added 73.69%
142,681 $17.2 Million
Q3 2017

Oct 31, 2017

BUY
$106.92 - $117.79 $8.78 Million - $9.68 Million
82,148
82,148 $9.62 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Channing Capital Management, LLC Portfolio

Follow Channing Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channing Capital Management, LLC with notifications on news.